Anna Kata

NPI 1821483629ActiveIndividual· Colon & Rectal Surgery· Fairfax, VA

Colon & Rectal Surgery in Fairfax, Virginia, trained at University of California, San Francisco School of Medicine (class of 2015). 183 Medicare patients in 2024, $69,014 paid; nearly all of their 74 Part D prescriptions were generic (97%). Myriad Genetic Laboratories, Inc. was the largest of 2 companies reporting payments in 2024, $171.19 in all, mostly food and beverage.

Overview

NPI	1821483629
Status	Active
Entity type	Individual
Sole proprietor	Yes
NPI issued	Mar 30, 2015
Last updated in NPPES	Apr 15, 2024
Certified by provider	Apr 15, 2024

Specialties and licenses

Taxonomy	Code	License	State
Colon & Rectal Surgery Primary	208C00000X	0101278849	VA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Colorectal Surgery (Proctology) (DC); Practitioner - Colorectal Surgery (Proctology) (VA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	183
Services billed	417 across 47 procedure codes
Paid by Medicare	$69,014

Part D prescriptions in 2024

Prescriptions (claims)	74 · 74 30-day fills
Patients	41
Total drug cost	$408.24
Generic share	97% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of California, San Francisco School of Medicine
Graduation year	2015
Medicare specialty	Colorectal Surgery (Proctology)
Secondary specialties	General Surgery
Telehealth	Offers telehealth